Stereotactic Radiotherapy after Incomplete Transarterial (Chemo-) Embolization (TAE\TACE) versus Exclusive TAE or TACE for Treatment of Inoperable HCC: A Phase III Trial (NCT02323360)

Background: Hepatocellular carcinoma (HCC) is the most frequent liver malignancy and a leading cause of cancer death in the world. In unresectable HCC patients, transcatheter arterial (chemo-) embolization (TAE/TACE) has shown a disease response in 15–55% of cases. Though multiple TAE/TACE courses c...

Descripción completa

Detalles Bibliográficos
Autores principales: Comito, Tiziana, Loi, Mauro, Franzese, Ciro, Clerici, Elena, Franceschini, Davide, Badalamenti, Marco, Teriaca, Maria Ausilia, Rimassa, Lorenza, Pedicini, Vittorio, Poretti, Dario, Solbiati, Luigi Alessandro, Torzilli, Guido, Ceriani, Roberto, Lleo, Ana, Aghemo, Alessio, Santoro, Armando, Scorsetti, Marta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9689962/
https://www.ncbi.nlm.nih.gov/pubmed/36421345
http://dx.doi.org/10.3390/curroncol29110692

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9689962/
https://www.ncbi.nlm.nih.gov/pubmed/36421345
http://dx.doi.org/10.3390/curroncol29110692

Ejemplares similares